Literature DB >> 17725482

Molecular signaling in bone regeneration.

H Bahar1, Dafna Benayahu, A Yaffe, I Binderman.   

Abstract

Regeneration is the ability of cells to restore lost or damaged tissues and organs in adults by pathways that mimic developmental processes. Although many of the molecular mechanisms that control cellular differentiation and growth during embryogenesis recur during fracture healing, these processes take place in a postnatal environment that is unique and distinct from those that exist during embryogenesis. Bone tissue has a remarkable capacity of regeneration without scarring. This article highlights central biological and molecular processes that are crucial in embryonic bone development. Several animal bone regeneration models are described. The patterns of gene expression during the regeneration process in the different models are reviewed. Exploring the similarities and the differences in the molecular processes in different models will contribute to the understanding of their potential in the processes of bone regeneration and tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17725482     DOI: 10.1615/critreveukargeneexpr.v17.i2.10

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  2 in total

1.  Poly(lactic-co-glycolic) acid/nanohydroxyapatite scaffold containing chitosan microspheres with adrenomedullin delivery for modulation activity of osteoblasts and vascular endothelial cells.

Authors:  Lin Wang; Chunyan Li; Yingxin Chen; Shujun Dong; Xuesi Chen; Yanmin Zhou
Journal:  Biomed Res Int       Date:  2013-06-11       Impact factor: 3.411

2.  Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells.

Authors:  Daniele Tibullo; Michelino Di Rosa; Cesarina Giallongo; Piera La Cava; Nunziatina L Parrinello; Alessandra Romano; Concetta Conticello; Maria V Brundo; Salvatore Saccone; Lucia Malaguarnera; Francesco Di Raimondo
Journal:  Front Pharmacol       Date:  2015-10-14       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.